Search

everythinglearnresearchcommunity

for

Search:↓

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Minoxidil significantly lowers blood pressure in patients with hard-to-treat hypertension, but can cause fluid retention and excessive hair growth.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

MK-386 reduces sebum DHT levels.

Clofazimine may be effective for treating ashy dermatosis.

The research helps understand how finasteride works and aids drug development.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Caribine from traditional Chinese medicine may help treat hair loss.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Corin helps control salt and sweat release in sweat glands.

Cortisone reductase deficiency can cause high androgen and cortisol levels and may be missed in women with similar symptoms.

Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Minoxidil helps treat severe high blood pressure.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.